The course, designed to provide training to interventionalists on the transradial approach, was held in Merit’s new state-of-the-art training facility in its European headquarters in Maastricht, the Netherlands. It took place on 25 and 26 February. The ThinkRadial programme serves to educate and train interventional cardiologists, interventional radiologists and vascular surgeons around the world about using the radial artery, as an alternative to the femoral artery, to gain access for interventional procedures.
Katia Orvin (Department of Cardiology, Rabin Medical Center, Petach Tikva, Israel) and others report in the American Journal of Cardiology that the CHA2DS2VASC score, which is used to assess the risk of stroke in patients with atrial fibrillation, could be used to predict the risk of all-cause mortality in patients undergoing percutaneous coronary intervention (PCI). They note that the score is “even better than” the Age, Creatinine, and Ejection Fraction (ACEF) score.
Corindus Vascular Robotics has appointed announced Mark Toland as chief executive officer and member of the Board of Directors. He replaced David Handler, who has announced his resignation.
A single-centre study published in the Journal of Invasive Cardiology noted that treatment with Cardiac Dimensions’ Carillon mitral contour system resulted in significant improvement of functional mitral regurgitation (FMR).
Biotronik has opened a new, state-of-the-art training facility and innovation centre in New York City, USA, according to a company release.
A meta-analysis of tirofiban hydrochloride (Aggrastat, Medicure) has been presented by primary investigator and lead author, Michael J Lipinski of the MedStar Heart and Vascular Institute, Washington, DC, presented the data at the 2016 Cardiovascular Research Technologies (CRT) conference.
Six years ago, a handful of researchers at Lund University in Sweden started taking an interest in how to make it easier to recognise unstable plaques that in worst case scenarios rupture and cause heart attacks or strokes.
Cardiac surgeons at the Montreal Heart Institute have published a report featured in the Annals of Thoracic Surgery detailing how active clearance of chest tubes in the intensive care unit non-surgically treated a life-threatening episode of pericardial tamponade in a patient recovering from heart surgery.
The first patient has been enrolled in the SynCor clinical trial of Xenios’ CE-marked i-cor synchronised cardiac assist system for treating cardiogenic shock.
Investigators will present new analyses from high-risk percutaneous coronary intervention (PCI) patient subgroups from the CHAMPION PHOENIX study with The Medicine Company’s antithrombotic agent, Kengreal (cangrelor) for injection at the 65th Annual Scientific Session of the American College of Cardiology, held April 2-4, in Chicago, USA.
Individuals with a greater degree of activity in the stress centre of the brain also have more evidence of inflammation in their arteries and may be at higher risk for cardiovascular events, including heart attack, stroke and death, according to a study scheduled for presentation at the American College of Cardiology’s 65th Annual Scientific Session.
Despite increased understanding of heart disease risk factors and the need for preventive lifestyle changes, patients suffering the most severe type of heart attack have become younger, more obese and more likely to have preventable risk factors such as smoking, high blood pressure, diabetes type two and chronic obstructive pulmonary disease, according to a study scheduled to be presented at the American College of Cardiology’s 65th Annual Scientific Session, Chicago, USA.
Boston Scientific is to present data spanning its interventional cardiology, rhythm management and structural heart portfolios at the American College of Cardiology’s 65th Annual Scientific Session which will be held in Chicago, USA, April 2-4.
Direct Flow Medical has launched the DirecTrack delivery system in Europe. DirecTrack is a next generation delivery system for the Direct Flow Medical transcatheter aortic valve system.
Zoll Medical has announced that its Japanese subsidiary, Asahi Kasei Zoll Medical, has obtained approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) to market the company’s Thermogard XP temperature management system for sudden cardiac arrest in Japan.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos